• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCIENCES PR ACCUDRAIN WITHOUT THE ANTI-REFLUX VALVE; N/A

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCIENCES PR ACCUDRAIN WITHOUT THE ANTI-REFLUX VALVE; N/A Back to Search Results
Catalog Number INS8400
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Cerebrospinal Fluid Leakage (1772)
Event Type  Injury  
Manufacturer Narrative
Investigation completed (b)(6) 2018.The device was not to be returned for evaluation; customer did not keep the device.The lot number for the event was not identified.A list of 22 possible lots was provided and no related quality events and/or non-conformances (ncs) were recorded for any of the lot numbers; therefore, it is concluded that each lot complied with all in-process inspections and testing requirements as specified in the manufacturing shop order and related procedures.This complaint is unconfirmed.As an internal control, all units are leak tested during the manufacturing process.The customer provided additional information in which it was stated that: ¿a large needle was used through the csf patient port to administer a chemotherapy drug.This is their protocol in emergency situations.¿ the ifu makes the following statements: ¿the smartsite needleless site can be accessed with any standard luer fitting syringe.¿ ¿do not insert a needle into the needleless sampling site.¿ thus, it is concluded that the root cause of this event is user related due to hospital protocol in which a large needle is used through the needleless port in emergency situations.
 
Event Description
The customer reported that on an unknown date, the ins8400 accudrain patient port leaked when administering an emergency oncology drug.This resulted in removal of the drain.Additional information received on (b)(6) 2018 that a large needle was used through the cerebrospinal (csf) patient port to administer a chemotherapy drug.There was no adverse report to the patient from the product.In the facility's opinion, this was not a product failure.The accudrain was going to be removed anyway.This is their protocol in emergency situations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCUDRAIN WITHOUT THE ANTI-REFLUX VALVE
Type of Device
N/A
Manufacturer (Section D)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
road 402 north, km 1.2
anasco PR 00610
Manufacturer (Section G)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
anasco PR 00610
Manufacturer Contact
rowena bunuan
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key7353392
MDR Text Key102945374
Report Number2648988-2018-00008
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K042825
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other
Type of Report Initial
Report Date 02/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberINS8400
Was Device Available for Evaluation? No
Date Manufacturer Received02/22/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-